Salt-Sensitive Hypertension: Mediation by Salt-Induced Hypervolemia and Phosphate-Induced Vascular Calcification

Preventing hypertension by restricting dietary salt intake, sodium chloride, is well established in public health policy, but a pathophysiological mechanism has yet to explain the controversial clinical finding that some individuals have a greater risk of hypertension from exposure to salt intake, termed salt-sensitive hypertension. The present perspective paper synthesizes interdisciplinary findings from the research literature and offers novel insights proposing that the pathogenesis of salt-sensitive hypertension is mediated by interaction of salt-induced hypervolemia and phosphate-induced vascular calcification. Arterial stiffness and blood pressure increase as calcification in the vascular media layer reduces arterial elasticity, preventing arteries from expanding to accommodate extracellular fluid overload in hypervolemia related to salt intake. Furthermore, phosphate has been found to be a direct inducer of vascular calcification. Reduction of dietary phosphate may help reduce salt-sensitive hypertension by lowering the prevalence and progression of vascular calcification. Further research should investigate the correlation of vascular calcification with salt-sensitive hypertension, and public health recommendations to prevent hypertension should encourage reductions of both sodium-induced hypervolemia and phosphate-induced vascular calcification.

[1]  Ronald B. Brown Hypertension, Anxiety and Obstructive Sleep Apnea in Cardiovascular Disease and COVID-19: Mediation by Dietary Salt , 2022, Diseases.

[2]  Hana A. Itani,et al.  Pathophysiology and genetics of salt-sensitive hypertension , 2022, Frontiers in Physiology.

[3]  Hongli Jiang,et al.  Prevalence and risk factors for vascular calcification based on the ankle-brachial index in the general population: a cross-sectional study , 2022, BMC Cardiovascular Disorders.

[4]  D. Ellison,et al.  Insights into Salt Handling and Blood Pressure. , 2021, The New England journal of medicine.

[5]  B. Hansen Fluid Overload , 2021, Frontiers in Veterinary Science.

[6]  J. Górriz,et al.  Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects , 2021, Frontiers in Medicine.

[7]  S. Haller,et al.  Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall , 2021, Biomedicines.

[8]  Olga Balafa,et al.  Salt sensitivity and hypertension , 2020, Journal of Human Hypertension.

[9]  A. Heinz Elastases and elastokines: elastin degradation and its significance in health and disease , 2020, Critical reviews in biochemistry and molecular biology.

[10]  G. Fuiano,et al.  Secondary Hyperparathyroidism and Hypertension: An Intriguing Couple , 2020, Journal of clinical medicine.

[11]  W. Farquhar,et al.  The Impact of High Dietary Sodium Consumption on Blood Pressure Variability in Healthy, Young Adults. , 2020, American journal of hypertension.

[12]  Paolo Salvi,et al.  Sodium Intake and Hypertension , 2019, Nutrients.

[13]  S. Carugo,et al.  The Key Role of Phosphate on Vascular Calcification , 2019, Toxins.

[14]  S. Nicholls,et al.  Coronary arterial calcification: A review of mechanisms, promoters and imaging. , 2018, Trends in cardiovascular medicine.

[15]  K. Lu,et al.  Mineral bone disorders in chronic kidney disease , 2018, Nephrology.

[16]  N. Ohte,et al.  Dietary Salt Intake is a Significant Determinant of Impaired Kidney Function in the General Population , 2018, Kidney and Blood Pressure Research.

[17]  Daohai Zhang,et al.  High Phosphate-Induced Calcification of Vascular Smooth Muscle Cells is Associated with the TLR4/NF-κb Signaling Pathway , 2017, Kidney and Blood Pressure Research.

[18]  T. Drueke,et al.  Vascular calcification in chronic kidney disease: here to stay? , 2017, Kidney international.

[19]  J. Guillaumin,et al.  Disorders of Sodium and Water Homeostasis. , 2017, The Veterinary clinics of North America. Small animal practice.

[20]  N. Cook,et al.  Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. , 2016, Hypertension.

[21]  M. Horie,et al.  Relationship of Insulin Resistance to Prevalence and Progression of Coronary Artery Calcification Beyond Metabolic Syndrome Components: Shiga Epidemiological Study of Subclinical Atherosclerosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[22]  K. Matthews,et al.  Inflammatory/hemostatic biomarkers and coronary artery calcification in midlife women of African-American and White race/ethnicity: the Study of Women's Health Across the Nation (SWAN) heart study , 2016, Menopause.

[23]  C. Hao,et al.  Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients , 2015, BMC Nephrology.

[24]  K. Masutani,et al.  Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. , 2014, American journal of physiology. Renal physiology.

[25]  L. Appel,et al.  High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. , 2014, The American journal of clinical nutrition.

[26]  C. Giachelli,et al.  Vascular Calcification: An Update on Mechanisms and Challenges in Treatment , 2013, Calcified Tissue International.

[27]  Elfi Furtmueller,et al.  Using grounded theory as a method for rigorously reviewing literature , 2013, Eur. J. Inf. Syst..

[28]  B. Lanske,et al.  FGF23 regulates renal sodium handling and blood pressure , 2012, EMBO molecular medicine.

[29]  C. Shanahan,et al.  Vascular calcification and hypertension: Cause and effect , 2012, Annals of medicine.

[30]  Jessica E Wagenseil,et al.  Elastin in Large Artery Stiffness and Hypertension , 2012, Journal of Cardiovascular Translational Research.

[31]  C. Shanahan,et al.  Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate , 2011, Circulation research.

[32]  John Cunningham,et al.  Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[33]  M. Zou,et al.  Arterial stiffness: a brief review , 2010, Acta Pharmacologica Sinica.

[34]  R. Foley,et al.  Serum phosphorus levels associate with coronary atherosclerosis in young adults. , 2009, Journal of the American Society of Nephrology : JASN.

[35]  D. Goldsmith,et al.  Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  M. Weinberger,et al.  Salt sensitivity of blood pressure in humans. , 1996, Hypertension.

[37]  G. Boss,et al.  Age-related physiological changes and their clinical significance. , 1981, The Western journal of medicine.

[38]  P. Dobrin,et al.  Mechanical properties of arteries , 1978, Physiological reviews.

[39]  THE WORLD HEALTH ORGANIZATION , 1954 .

[40]  P. Whelton,et al.  Hypertension , 1942, Nature Reviews Disease Primers.

[41]  OUP accepted manuscript , 2022, European Heart Journal.

[42]  D. Haffner,et al.  Phosphate Is a Cardiovascular Toxin. , 2022, Advances in experimental medicine and biology.

[43]  Phosphate Metabolism: From Physiology to Toxicity , 2022, Advances in Experimental Medicine and Biology.

[44]  L. Lun,et al.  Impacts of parathyroidectomy on calcium and phosphorus metabolism disorder, arterial calcification and arterial stiffness in haemodialysis patients. , 2019, Asian journal of surgery.

[45]  Qiaoling Chen,et al.  Parathyroidectomy for Patients With Primary Hyperparathyroidism and Associations With Hypertension. , 2019, JAMA surgery.

[46]  M. Razzaque,et al.  Endocrine Regulation of Phosphate Homeostasis , 2018 .

[47]  L. Hutchison,et al.  BONE METABOLISM AND DISEASE IN CHRONIC KIDNEY DISEASE , 2007 .